Stegemann, Sven
81  Ergebnisse:
Personensuche X
?
2

Patient engagement in pharmaceutical development: Where are..:

Stegemann, Sven ; Birna Almarsdόttir, Anna ; Vermehren, Charlotte
European Journal of Pharmaceutics and Biopharmaceutics.  185 (2023)  - p. 1-4 , 2023
 
?
3

Patient-centric drug product development: Acceptability acr..:

Stegemann, Sven ; Klingmann, Viviane ; Reidemeister, Sibylle.
European Journal of Pharmaceutics and Biopharmaceutics.  188 (2023)  - p. 1-5 , 2023
 
?
4

Focusing on powder processing in dry powder inhalation prod..:

Stegemann, Sven ; Faulhammer, Eva ; Pinto, Joana T.
International Journal of Pharmaceutics.  614 (2022)  - p. 121445 , 2022
 
?
5

Response to "Letter to the Editor" from Lode Dewulf and Jim..:

Stegemann, Sven
European Journal of Pharmaceutics and Biopharmaceutics.  181 (2022)  - p. 310 , 2022
 
?
6

Rational and practical considerations to guide a target pro..:

Stegemann, Sven ; Sheehan, Liz ; Rossi, Alessandra...
European Journal of Pharmaceutics and Biopharmaceutics.  177 (2022)  - p. 81-88 , 2022
 
?
 
?
8

An evaluation of film coating materials and their predicted..:

Drumond, Nélio ; Stegemann, Sven
Journal of Drug Delivery Science and Technology.  77 (2022)  - p. 103804 , 2022
 
?
10

Merging Science and Patient in Future Drug Development to E..:

Stegemann, Sven
Acta Pharmaceutica Hungarica.  91 (2021)  3-4 - p. 97-98 , 2021
 
?
12

Demographics in the 2020s—Longevity as a challenge for phar..:

Stegemann, Sven ; van Riet‐Nales, Diana ; de Boer, Anthonius
British Journal of Clinical Pharmacology.  86 (2020)  10 - p. 1899-1903 , 2020
 
?
13

Challenges and opportunities to include patient‐centric pro..:

Timpe, Carsten ; Stegemann, Sven ; Barrett, Andrew.
British Journal of Clinical Pharmacology.  86 (2020)  10 - p. 2020-2027 , 2020
 
1-15